| Structure | Chemical Name | CAS | MF |
|
Fatty acids, tall-oil, polymers with adipic acid and pentaerythritol
|
114096-19-4
|
|
|
1,3-Benzenedicarbonyl dichloride, polymer with 1,4-benzenedicarbonyl dichloride, carbonic dichloride and 4,4-(1-methylethylidene)bisphenol, bis4-(1-methyl-1-phenylethyl)phenyl ester
|
114096-64-9
|
C47H40Cl6O8
|
|
Furo[3,4-b]quinoxaline, 1,3-dihydro-
|
114096-83-2
|
C10H8N2O
|
|
ethyl 3-hydroxypyrido[2,3-b]pyrazine-2-carboxylate
|
114097-17-5
|
C10H9N3O3
|
|
N-(3,4-dimethylphenyl)-4-methylbenzenesulfonamide（WS203334）
|
114097-27-7
|
C15H17NO2S
|
|
Thiazolo[4,5-f]benzoxazole, 2,6-dimethyl- (6CI)
|
114097-57-3
|
C10H8N2OS
|
|
Dibutyramide, 2-methyl- (6CI)
|
114097-59-5
|
C9H17NO2
|
|
1,3-Oxazine,tetrahydro-3-isopropyl-2-vinyl-(6CI)
|
114098-04-3
|
C9H17NO
|
|
Butyramide, N-isobutyryl-2-methyl- (6CI)
|
114098-09-8
|
C9H17NO2
|
|
sarasinoside A1
|
114099-54-6
|
C62H100N2O26
|
|
Fraision butyrate
|
114099-96-6
|
C10H14O4
|
|
methyl 2,3-dideoxy-3-fluoro-α-D-erythro-pentafuranoside
|
114100-05-9
|
C6H11FO3
|
|
N-(3-Aminomethyl-phenyl)-methanesulfonamide
|
114100-09-3
|
C8H12N2O2S
|
|
|
Herculite Condensable
|
114100-34-4
|
|
|
|
proto-oncogene mbcl-2 beta protein
|
114100-40-2
|
|
|
|
proto-oncogene mbcl-2 alpha protein
|
114100-41-3
|
|
|
|
Salbupart
|
114101-13-2
|
|
|
|
atrial natriuretic factor (1-98)
|
114101-49-4
|
|
|
atrial natriuretic factor (1-28), Ala(26)-
|
114102-57-7
|
C121H199N45O39S3
|
|
2-Nitrophenyl6-O-trityl-b-D-galactopyranoside
|
114102-89-5
|
C31H29NO8
|
|
4-Azabicyclo[6.4.1]trideca-2,4,6,8,10,12-hexaene,5-ethoxy-(9CI)
|
114105-50-9
|
C14H15NO
|
|
2-[Hydroxy-(4-nitro-phenyl)-methyl]-acrylic acid methyl ester
|
114106-93-3
|
C11H11NO5
|
|
Diethyl(methanesulfonyloxymethyl)phosphonate, 97 %
|
114108-84-8
|
C6H15O6PS
|
|
2-Chloromethyl-4,6-dimethoxypyrimidine
|
114108-86-0
|
C7H9ClN2O2
|
|
Cyclohexyl(ethyl)sulfamoyl chloride
|
114108-87-1
|
C8H16ClNO2S
|
|
(4-Chloro-2-fluoro-phenyl)-carbamic acid ethyl ester
|
114108-90-6
|
C9H9ClFNO2
|
|
Benzene, 1,5-dichloro-2-nitro-4-(phenylmethoxy)-
|
114109-50-1
|
C13H9Cl2NO3
|
|
3-Buten-2-one, 4-hydroxy-4-(phenylamino)-
|
114113-11-0
|
C10H11NO2
|
|
Ethanone, 1-(4,5-dihydro-5-hydroxy-5-isoxazolyl)- (9CI)
|
114113-84-7
|
C5H7NO3
|
|
(3,5-Dibromo-4-methoxyphenyl)methanol
|
114113-99-4
|
C8H8Br2O2
|
|
7,7'-azocholestane-25-diol
|
114115-27-4
|
C27H46N2O2
|
|
18-carboxy-19,20-dinor-N-acetylleukotriene E4
|
114115-51-4
|
C23H33NO8S
|
|
16-carboxy-17,18,19,20-tetranor-14,15-dihydro-N-acetylleukotriene E4
|
114115-52-5
|
C21H31NO8S
|
|
chlorovinylglycine
|
114115-56-9
|
|
|
8-(2-carboxymethylthio)-cGMP
|
114115-66-1
|
C12H14N5O9PS
|
|
Boc-Phe(4-NHAc)-OH
|
114117-42-9
|
C16H22N2O5
|
|
2(Z)-Butene-1,4-diamine,dihydrochloride
|
114118-70-6
|
C4H12Cl2N2
|
|
2-Benzothiazolamine,7-chloro-6-methoxy-(9CI)
|
114118-80-8
|
C8H7ClN2OS
|
|
tirandalydigin
|
114118-91-1
|
C22H27NO6
|
|
Fmoc-Leu-ODhbt
|
114119-83-4
|
C28H26N4O5
|
|
Fmoc-Asp(OBut)-ODhbt
|
114119-84-5
|
C30H28N4O7
|
|
Fmoc-Pro-ODhbt
|
114119-85-6
|
C27H22N4O5
|
|
Fmoc-Glu(OBut)-ODhbt
|
114119-86-7
|
C31H30N4O7
|
|
Fmoc-Gly-ODhbt
|
114119-87-8
|
C24H18N4O5
|
|
Fmoc-Lys(Boc)-ODhbt
|
114119-89-0
|
C33H35N5O7
|
|
Fmoc-Phe-ODhbt
|
114119-90-3
|
C31H24N4O5
|
|
N-nitroso-N(2)-fluorenylacetamide
|
114119-92-5
|
C15H12N2O2
|
|
P(3)-1-(2-nitrophenyl)ethylcytidine-5'-triphosphate
|
114119-93-6
|
C17H23N4O16P3
|
|
2,5,7,7-Tetramethyloctanal
|
114119-97-0
|
C12H24O
|
|
5-Isoxazolecarboxylicacid,4,5-dihydro-,ethylester(9CI)
|
114120-87-5
|
C6H9NO3
|
|
3-(2'-phenyl-2'-cyclopentyl-2'-hydroxyethoxy)quinuclidine
|
114121-68-5
|
C20H29NO2
|
|
Cyclohexane, 1,1,5,5-tetramethyl-2-(1-methylethenyl)-3-(2,2,4-trimethylpentyl)-, cis- (9CI)
|
114123-73-8
|
C21H40
|
|
Methyl 3,3,3-trifluoro-2-hydroxy-2-(1H-indol-3-yl)propanoate
|
114125-58-5
|
C12H10F3NO3
|
|
Butanoic acid, 2-(acetylmethylamino)-
|
114126-84-0
|
C7H13NO3
|
|
trichostatic acid
|
114127-17-2
|
C17H21NO3
|
|
(R)-Trichostatic Acid
|
114127-18-3
|
C17H21NO3
|
|
Phenol, 4-[(2R,3S)-4-(1,3-benzodioxol-5-yl)-2,3-dimethylbutyl]-2-methoxy-, rel-
|
114127-24-1
|
C20H24O4
|
|
5β-4,5-Dihydro Prednisolone 21-Acetate
|
114127-54-7
|
C23H32O6
|
|
[1S-(1α,2β,5α)]-5-Methyl-2-(1-Methylethyl)cyclohexyl β-D-Glucopyranosiduronic Acid
|
114127-73-0
|
C16H28O7
|
|
MAJOROSIDE-F1
|
114128-16-4
|
C48H82O19
|
|
Cyclohexanone, 5-methyl-2-(1-methylethyl)-, oxime, [2S-(1Z,2alpha,5ba)]- (9CI)
|
114129-78-1
|
C10H19NO
|
|
3(2H)-Isoquinolinone,7,8-dimethoxy-(9CI)
|
114130-68-6
|
C11H11NO3
|
|
Cyclopropylmethanesulfonyl chloride
|
114132-26-2
|
C4H7ClO2S
|
|
4-carboxy-6-(mercaptomethyl)-3,4,5,6-tetrahydropyrimidin-2(1H)-one
|
114132-84-2
|
C6H10N2O3S
|
|
(s)-3-(methylamino)-1-phenylpropanol (114133-37-8)
|
114133-37-8
|
C10H15NO
|
|
Hexanedioic acid, polymer with N-(2-aminoethyl)-1,3-propanediamine, aziridine, (chloromethyl)oxirane, 1,2-ethanediamine, N,N-1,2-ethanediylbis1,3-propanediamine, formic acid and .alpha.-hydro-.omega.-hydroxypoly(oxy-1,2-ethanediyl)
|
114133-44-7
|
(C8H22N4.C6H10O4.C5H15N3.C3H5ClO.C2H8N2.C2H5N.(C2H4O)nH2O.CH2O2)x
|
|
3-(4-chloro-2-fluorophenyl)-1-methyl-6-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione
|
114136-66-2
|
C12H7ClF4N2O2
|
|
3-(5-amino-4-chloro-2-fluorophenyl)-1-methyl-6-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione
|
114136-76-4
|
C12H8ClF4N3O2
|
|
N,N'-Bis(2-methyl-2-nitropropyl)hexamethylenediamine
|
114136-87-7
|
C14H30N4O4
|
|
ALDOSTATIN
|
114137-09-6
|
C20H20N2O8
|
|
4-[4-[4,6-Bis[3-(diethylamino)propylamino]-1,3,5-triazin-2-ylamino]phenylazo]-3-methyl-1-phenyl-1H-pyrazol-5-ol
|
114138-05-5
|
C33H48N12O
|
|
5-hydroxy-3-phenyl-1-(phenyl)-1H-pyrazole
|
114138-49-7
|
C15H12N2O
|
|
Bicyclo[2.2.1]heptane-2-carboxaldehyde, 3-hydroxy- (9CI)
|
114140-88-4
|
C8H12O2
|
|
(2S,5S)-2,5-dimethylpyrrolidine:hydrochloride
|
114143-75-8
|
C6H13N.ClH
|
|
Pyrrolidine, 1-(1-butynyl)-2-methyl- (9CI)
|
114143-76-9
|
C9H15N
|
|
6-Iodo-2,3-dihydro-1H-indole
|
114144-16-0
|
C8H8IN
|
|
7-chloroindoline
|
114144-22-8
|
C8H8ClN
|
|
14(15)-epoxytetraene
|
114144-28-4
|
C20H30O4
|
|
1,7-dibenzyl-8-bromo-3-methyl-3,7-dihydro-1H-purine-2,6-dione
|
114145-28-7
|
C20H17BrN4O2
|
|
Butanoic acid, glycylglycyl-2-amino- (9CI)
|
114148-83-3
|
C8H15N3O4
|
|
Butanoic acid, 2-[[2-[(aminoacetyl)amino]-1-oxobutyl]amino]- (9CI)
|
114148-85-5
|
C10H19N3O4
|
|
H-Ile-Ile-Ile-OH
|
114148-95-7
|
C18H35N3O4
|
|
3-(5-(4-chlorophenyl)-1-(4-methoxyphenyl)-1H-pyrazol-3-yl)propanoic acid
|
114150-42-4
|
C19H17ClN2O3
|
|
4,6-Dioxo-6-phenylhexanoic acid
|
114150-57-1
|
C12H12O4
|
|
Benzoic acid,2,3,6-trifluoro-5-nitro-
|
114151-54-1
|
C7H2F3NO4
|
|
2,3,6-Trifluorobenzyl alcohol
|
114152-19-1
|
C7H5F3O
|
|
2,3,6-Trifluorobenzyl chloride
|
114152-20-4
|
C7H4ClF3
|
|
2,3,6-Trifluorophenylacetonitrile
|
114152-21-5
|
C8H4F3N
|
|
2,3,6-Trifluorophenylacetic acid
|
114152-23-7
|
C8H5F3O2
|
|
rel-(1R,2S)-2-Fluorocyclopropan-1-amine hydrochloride
|
114152-95-3
|
C3H6FN.ClH
|
|
Trans-2-fluorocyclopropanamine hydrochloride
|
114152-96-4
|
C3H6FN.ClH
|
|
3,4-difluoro-2-methylaniline
|
114153-09-2
|
C7H7F2N
|
|
N-(3-Chloro-2-methyl-phenyl)-2,2-dimethyl-propionamide
|
114153-36-5
|
C12H16ClNO
|
|
kanglemycin A
|
114153-91-2
|
C50H63NO19
|
|
(+/-)-3,3,3-trifluoro-2-hydroxy-2-(1-methyl-2-phenylindol-3-
yl)propionic acid methyl ester
|
114155-19-0
|
C19H16F3NO3
|
|
5'-O-(9-phenylxanthen-9-yl)-2'-deoxynebularine
|
114155-96-3
|
C29H24N4O4
|
|
3'-O-((N,N-diisopropylamino)(2-cyanoethoxy)phosphinyl)-5'-O-(9-phenylxanthen-9-yl)-2'-deoxynebularine
|
114155-97-4
|
C38H41N6O6P
|
|
5-Hexyn-2-one, 3-fluoro- (9CI)
|
114156-31-9
|
C6H7FO
|
|
1,1'-Bi(cyclohexyl)-2-carboxylic acid Other Name Bicyclohexyl-2-carboxylic acid
|
114160-21-3
|
C13H22O2
|
|
Carbamic acid, dihydro-5-2-methyl-5-(nonylphenoxy)carbonylaminophenyl-2,4,6-trioxo-1,3,5-triazine-1,3(2H,4H)-diylbis(6-methyl-3,1-phenylene)bis-, bis(nonylphenyl) ester
|
114162-62-8
|
|